A multiple dose pilot comparison of tiotropium inhalation capsules and salmeterol inhalation aerosol combined with fluticasone inhalation aerosol in a six-week, randomized, double-blind, triple-dummy parallel group study in patients with chronic obstructive pulmonary disease (COPD)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tiotropium bromide (Primary) ; Fluticasone propionate; Salmeterol
Indications Chronic obstructive pulmonary disease
Focus Therapeutic Use
Sponsors Boehringer Ingelheim

Most Recent Events

25 Jul 2007 The expected completion date for this trial is now 1 Aug 2004.
22 Nov 2005 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight